TGFB1 and neoplasm: Tumor cell-derived TGF-β stimulates reactive oxygen species (ROS)-dependent expression of α-smooth muscle actin in the fibroblasts leading to their differentiation into myofibroblasts [45], offering the theoretical possibility of therapeutically preventing this conversion with ROS scavengers like N-acetyl-cysteine.